Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-03-25An Eight-Week, Double-Blind, Placebo-Controlled, Multicenter Study With Paroxetine (10 mg qd) as Positive Control, Evaluating the Efficacy, Safety, Tolerability of Two Fixed Doses of SR58611A (175 mg q12/ 350 mg q12) in Outpatients With MDD
-
CLINICAL_TRIALS study record update · 2009-03-25A Multi-National, Multi-Center, DB, Placebo-Controlled, Parallel Group, Fixed Dose Efficacy & Safety Study of SR58611A 350 mg Twice Daily vs. Placebo in Adults With Major Depressive Disorder on Concomitant Treatment With Escitalopram 10mg/d
-
CLINICAL_TRIALS study record update · 2009-03-25A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR®) as Mono-Therapy in the Treatment of Adult Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2009-03-25An Open-Label, Non-Comparative, Multi-Centre, Phase II Prospective Trial to Assess the Efficacy of Quetiapine Fumarate Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) in SSRI-Resistant Major Depressive Disorder.
-
CLINICAL_TRIALS study record update · 2009-03-25A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained-Release (SEROQUEL®) as Monotherapy in the Treatment of Patients With MDD
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-03-13The Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response: A Comparison of Premenopausal, Perimenopausal and Postmenopausal Women
-
CLINICAL_TRIALS study record update · 2009-03-12An Eight-Week, Double-Blind, Placebo Controlled, Multicenter Study With Escitalopram (10 mg qd) as Positive Control, Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Outpatients With MDD
-
CLINICAL_TRIALS study record update · 2009-03-12An Eight-Week, Double-Blind, Placebo Controlled, Multicenter Study With Escitalopram (10 mg qd) as Positive Control, Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Outpatients With MDD
-
CLINICAL_TRIALS study record update · 2009-03-06Integrated CBT for Substance Use and Depressive Disorders
-
CLINICAL_TRIALS study record update · 2009-02-17Deep Brain Stimulation for Refractory Major Depression
-
CLINICAL_TRIALS study record update · 2009-02-17Memory Functioning and Antidepressant Treatment: A Randomized Controlled Trial Comparing Escitalopram and Bupropion XL
-
CLINICAL_TRIALS study record update · 2008-12-22A Multi-Centre, Double-Blind, Randomised, Parallel Group, Placebo- Controlled and Active Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) as Mono- Therapy in the Treatment of Adult Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2008-12-05A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DOV 21,947 in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2008-10-10ClinicalTrials.gov study NCT00265291
-
CLINICAL_TRIALS study record update · 2008-09-25EEG Biomarkers of Response in Depression
-
CLINICAL_TRIALS study record update · 2008-09-01Stress Generation and Recurrent Depression: The Role of Differential Treatment Response
-
CLINICAL_TRIALS study record update · 2008-09-01Patient Dimensions as Predictors of Response, Relapse and Recurrence Following Cognitive-Behavioral Therapy, Interpersonal Psychotherapy and Pharmacotherapy Treatment of Patients With Major Depression.
-
CLINICAL_TRIALS study record update · 2008-08-15High Cortisol Levels as a Risk Factor for Depression in the Elderly and the Effect of Bright Light Treatment on Mood, Sleep-Wake Pattern and Self-Sufficiency
-
CLINICAL_TRIALS study record update · 2008-07-14Fluoxetine vs. Brief Psychotherapy in the Treatment of Major Depression - a Randomized Comparative Study
-
CLINICAL_TRIALS study record update · 2008-05-28The Use of Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2008-03-31Prospective, Double Blind, Randomized, Placebo-Controlled Dose Finding Study of the Efficacy and Safety of 2 Target Doses of Org 34517 Used as Adjunct"
-
CLINICAL_TRIALS study record update · 2008-01-31ClinicalTrials.gov study NCT00229398
-
CLINICAL_TRIALS study record update · 2008-01-29ClinicalTrials.gov study NCT00294944
-
CLINICAL_TRIALS study record update · 2008-01-15A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group, Flexible Dose Titration, Add-On Study of Mecamylamine 5.0 to 10 mg, in the Treatment of Major Depressive Disorder With Subjects Who Are Partial or Non- Responders to Citalopram Therapy.
-
CLINICAL_TRIALS study record update · 2008-01-07Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients